Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
Issue Archive
> September 2008 Issue of MMM
September 2008 43 9 Issue of MMM
Editor's Desk
Why do you do what you do?
We all have a pretty good idea of what the average person in the street might think of big pharma, and the chances are it's ...
Features
Career & Salary Survey: Down in the Count
The brutal economic landscape is taking its toll on industry paychecks--for the first time in years, MM&M's exclusive research shows a decrease in average salary. ...
Office Party
While some organizations find the talent shortage to be a struggle, several firms have managed to attract and retain staff by creating a culture and ...
Seven Paths to Pharma
The road to a successful career in healthcare marketing can be a long and winding one, and is often fraught with questionable positions such as ...
Merger Made in Heaven
We've all heard horror stories about ugly mergers stifling innovation and crushing employee morale, but Takeda's hands-off melding with Millennium and AstraZeneca's absorption of MedImmune ...
MM&M Awards Finalists 2008
The results are in from our panel of industry experts—the shortlist for each of the 24 categories appear on the following pages. The winners will ...
Headliner: Shire's Angus Russell
Angus Russell took over as CEO of Shire in June after serving nine years as CFO and EVP of global finance.
Antidote
Antidote
My usual purpose in Antidote is to champion a drug that has been unfairly maligned.
In Focus
New regs exorcising the devil in the details
Goodbye, branded notepads, pens, mousepads and stress-balls.
Med Ed Report
Surprise! Massachusetts ban on gifts for doctors is back
When Massachusetts' House of Representatives passed a big healthcare bill in early July, drug and device makers and data firms thought they'd ducked a bullet ...
ACCME calls for comment on proposed policies
ACCME called for comment on proposed policies aimed at limiting interactions between accredited providers and commercial interests, as well as its proposal "that due consideration ...
Overstreet recognized by NC-CME
Karen Overstreet, president of Indicia Medical Education and past president of NAAMECC, became one of the first medical educators to be recognized as a Certified ...
Accredited providers to face higher ACCME fees
Accredited CME providers will face higher fees from ACCME in 2011, along with a one-time additional assessment to accredited providers payable in 2009 as part ...
France halts implementation of new national CME system
France's health minister halted implementation of a new national CME system, originally slated to be implemented at the end of 2007.
Professional Media
Nielsen, Wolters Kluwer form alliance
In an effort to raise the bar on consumer health targeting, messaging and measurement, Nielsen and Wolters Kluwer Health have launched HealthScape, an information platform.
Doctors' Choice names top ads
The Association of Medical Media announced 13 finalists in The Doctors' Choice awards for best journal ads.
Oncology News International redesigns content offering
CMPMedica-owned Oncology News International has redesigned its content offering.
Study: 73% of pharmas have brand plans in place by Phase II
A new study from Cutting Edge Information found that 73% of pharmas have brand publication plans in place by the end of Phase II development.
Elsevier launches Clinical Simulation in Nursing
Elsevier, in partnership with the International Nursing Association for Clinical Simulation and Learning, has launched Clinical Simulation in Nursing.
The Triological Society will publish The Laryngoscope
Wiley-Blackwell—through a partnership with the American Laryngological—Rhinological and Otological Society, Inc. (The Triological Society), will publish The Laryngoscope, the society's official publication.
Media Forum
Seeking to track the unmeasurable
Professional media planners and buyers are increasingly called upon to provide solid ROI in a space where quantifiable metrics are difficult to obtain. What are ...
Direct Marketing
Abbott, AZ team up to promote Crestor
Seeking to increase its share of voice without beefing up its sales force, AstraZeneca is partnering with Abbott on a co-promotion of Crestor in the ...
Publicis acquires Google's Performics
Publicis Groupe has announced the acquisition of Performics, a Google search marketing business.
Social networks hinder marketing
The rising popularity of social networks has had a negative impact on email marketing, according to a new report.
DMA: survey text messages more effective than email
A Direct Marketing Association (DMA) report has found that mobile text messaging is a more effective tool than e-mail, mobile web and coupons.
Robinson Radio launches Robinson Radio Networks
Robinson Radio—an agency specializing in direct response radio—has launched Robinson Radio Networks (RNN), an advertising firm dedicated to developing, producing and placing long-form radio programming.
SDI unveils Physician Practice Profiling Report
SDI has launched the Physician Practice Profiling (P3) Report, a patient-level data analytics tool.
inVentiv Health acquires Patient Marketing Group
inVentiv Health has acquired Patient Marketing Group (PMG), a pharmaceutical marketing services firm specializing in patient relationship marketing.
DTC Report
Parade to launch 'healthy' supplement
Parade Magazine's monthly health supplement, HealthyStyle, debuts Sept. 17, and the publisher hopes it will prove a lure for pharma advertisers.
J&J may consolidate Rx advertising
Johnson & Johnson is considering consolidating advertising and marketing for its pharmaceutical brands into one or possibly two companies, a J&J spokesperson told MM&M.
FDA will survey how visuals distract viewers
The FDA will test broadcast-style ads for a bogus blood pressure drug as part of a survey aimed at determining how visuals may distract viewers ...
Warner Chilcott to limit DTC, rely more on reps
Warner Chilcott said it would "make much more limited use of DTC in support of our existing brands," relying instead on reps to drive market ...
PhRMA sends lawyers to meet with HECC staff
PhRMA sent a delegation of lawyers to meet with House Energy and Commerce Committee staffers to try and head off new regulations and discuss recent ...
Digital Media
Web Watch
Search continues to gain ground on email as the killer app on the Internet.
Ooga Labs to launch free encyclopedia
Medpedia, a free public website slated to launch by the end of 2008, hopes to offer the largest collaborative online encyclopedia of medicine.
Abbott rolls out Crohn's podcast series
Abbott has launched a series of podcasts, or "Crohn's Casts," offering information and insights into Crohn's disease.
Public Relations
PR View by Rob Rogers
Let's be clear. As one who has spent half a life working in the increasingly regulated "pay for what you get" advertising side of the ...
Xperience Comms: 'Think of doctors as consumers'
Joseph Wenke, partner and creative director at Xperience Communications, says bringing marketing principles into discussions with doctors makes sense.
Bayer, Jonas bro urging diabetes care
Bayer Diabetes Care has partnered with Nick Jonas for a campaign urging young people to proactively manage diabetes.
Marketing Research
Vantage Point
Having recently returned from speaking and listening at the 2008 EphMRA meeting in Barcelona, and with PMRG and PBIRG spring conferences already behind us, the ...
Pharma: suppliers lack 'insightful deliverables'
A study surveying top pharma companies found that market research (MR) buyers are largely unsatisfied with supplier results.
Verispan acquired by data rival SDI
Verispan has been bought by rival healthcare analytics firm SDI for an undisclosed price.
Washington Insider
As I see it
Another bad idea from government policy wonks surfaced in July when an FDA enforcement director told the Wall Street Journal his agency is using press ...
Jenkins predicts historic changes from FDA Acts
Last year's FDA Amendments Act will bring historic change to the agency and the industry, the likes of which has not been experienced for decades, ...
Sen. Brown renews outsourcing probe
Sen. Sherrod Brown (D-OH) is renewing his probe into the effect of drug company outsourcing on drug safety by asking Merck to explain the safety ...
Tougher FDA enforcement in the works
House Energy and Commerce Committee chairman John Dingell (D-MI) is circulating a revised draft of his proposed FDA Globalization Act, incorporating changes negotiated by committee ...
Agency's New Drug Application approvals up 18% in '08
New drug approval reports seem to cast doubt on critics' charges that the FDA has raised the bar in obtaining drug approvals.
GlaxoSmithKline hires Dan Troy as general counsel
GlaxoSmithKline has hired former FDA chief counsel and First Amendment specialist Dan Troy as its new general counsel.
Woodcock: black boxes shouldn't be the 'new warnings section'
Responding to criticism of why it took 15 years to order a black box for fluoroquinolones, the FDA's Janet Wood-cock said: "If we put every ...
Reps. introduce legislation to reverse medical device decision
In a move that has implications for drugmakers seeking relief from state court product liability lawsuits, Reps. Pallone (D-NJ) and Waxman (D-CA) have introduced legislation ...
HECC ranking member Barton introduces HR 6378
House Energy and Commerce Committee ranking member Joe Barton (R-TX) and 10 co-sponsors introduced HR 6378.
Back Talk
Diversity: A natural evolution
Today, we kneel to the Internet and the opportunities it has made possible.
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Pharmas are from Mars, Payers are from Venus
No-see docs are know-nothings when it comes to new drug info, study suggests
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Coach vs. cancer in BMS-backed awareness effort
Harvard urges faculty to ditch journals
Study: Young Latinas are key decision makers, prefer English
Pharma Report 2012: Get Back in Shape
Massachusetts gift ban under attack (again)
Pfizer, Crestor tops for global promotional spend in 2011
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Med Ed Report: Show Me the Money
No-see docs are know-nothings when it comes to new drug info, study suggests
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Mobile
Sales Force